trismik/FinRAG huggingface dataset:
dividends for a summary of the cash dividends paid on citi 2019s outstanding common stock during 2009 and 2010 , see note 33 to the consolidated financial statements .
for so long as the u.s .
government holds any citigroup trust preferred securities acquired pursuant to the exchange offers consummated in 2009 , citigroup has agreed not to pay a quarterly common stock dividend exceeding $ 0.01 per quarter , subject to certain customary exceptions .
further , any dividend on citi 2019s outstanding common stock would need to be made in compliance with citi 2019s obligations to any remaining outstanding citigroup preferred stock .
performance graph comparison of five-year cumulative total return the following graph and table compare the cumulative total return on citigroup 2019s common stock with the cumulative total return of the s&p 500 index and the s&p financial index over the five-year period extending through december 31 , 2010 .
the graph and table assume that $ 100 was invested on december 31 , 2005 in citigroup 2019s common stock , the s&p 500 index and the s&p financial index and that all dividends were reinvested .
citigroup s&p 500 index s&p financial index comparison of five-year cumulative total return for the years ended 2006 2007 2008 2009 2010 .

DECEMBER 31,
CITIGROUP
S&P 500 INDEX
S&P FINANCIAL INDEX
2006
119.55
115.79
119.19
2007
66.10
122.15
96.98
2008
15.88
76.96
43.34
2009
7.85
97.33
50.80
2010
11.22
111.99
56.96

.

Question: Analyse this data from a financial earnings document. in 2007 what was the ratio of the cumulative total return for citigroup to s&p 500 index
Choices:
0.46631
0.54114
0.55291
-0.54114
122.15
Correct choice index: 1
Other Current Liabilities
The components of other current liabilities are included in the following table (in thousands):

December 31,
2019
2018
Operating lease liabilities
$15,049
$ —
Vendor financed licenses
9,667
3,551
Royalties payable
6,107
11,318
Accrued interest
9,212
8,407
Other
36,936
38,412
Total other current liabilities
$76,971
$61,688


Question: Analyse this data from a financial earnings document. What was the change in accrued interest between 2018 and 2019?
Choices:
3105
-805
1
805
2911
Correct choice index: 3
Accrued expenses and other consist of the following (in thousands):
At December 31, 2019 and 2018, accounts receivable, accounts payable and accrued expenses are not measured at fair value; however, the Company believes that the carrying amounts of these assets and liabilities are a reasonable estimate of their fair value because of their relative short maturity.

December 31,
2019
2018
Accrued advertising expense
$1,774
$1,875
Accrued compensation expense
2,955
2,813
Reserve for member refunds
293
382
Other accrued expenses
2,455
2,266
Deferred rent
—
517
Total accrued expenses and other
$7,477
7,853


Question: Analyse this data from a financial earnings document. What is the change in accrued compensation expense between 2018 and 2019?
Choices:
0
-142
5768
142
5040
Correct choice index: 3
there were no share repurchases in 2016 .
stock performance graph the graph below matches fidelity national information services , inc.'s cumulative 5-year total shareholder return on common stock with the cumulative total returns of the s&p 500 index and the s&p supercap data processing & outsourced services index.aa the graph tracks the performance of a $ 100 investment in our common stock and in each index ( with the reinvestment of all dividends ) from december 31 , 2011 to december 31 , 2016. .

12/11
12/12
12/13
12/14
12/15
12/16
Fidelity National Information Services, Inc.
100.00
134.12
210.97
248.68
246.21
311.81
S&P 500
100.00
116.00
153.58
174.60
177.01
198.18
S&P Supercap Data Processing & Outsourced Services
100.00
126.06
194.91
218.05
247.68
267.14

the stock price performance included in this graph is not necessarily indicative of future stock price performance .
item 6 .
selected financial ss the selected financial data set forth below constitutes historical financial data of fis and should be read in conjunction with "item 7 , management 2019s discussion and analysis of financial condition and results of operations , " and "item 8 , financial statements and supplementary data , " included elsewhere in this report. .

Question: Analyse this data from a financial earnings document. what is the total return if $ 100000 are invested in s&p500 in 12/11 and sold in 12/16?
Choices:
1963600
98180.0
98378.2
191180
214.1
Correct choice index: 1
Note 12. Liabilities
The components of accounts payable, accrued expenses and other current liabilities are as follows (in thousands):

December 31, 2019
December 31, 2018
Accounts payable
$32,878
$20,214
Accrued expenses
10,092
34,557
Subsidiary unit awards
141
200
Other current liabilities
5,616
3,459
Accounts payable, accrued expenses and other current liabilities
$48,727
$58,430


Question: Analyse this data from a financial earnings document. What was the change in the Subsidiary unit awards between 2018 and 2019?
Choices:
0
28200
-708
-9951
-59
Correct choice index: 4
6. Inventories
Inventories consisted of the following components at June 30, 2019 and 2018:
If the FIFO method of inventory had been used instead of the LIFO method, inventories would have been $178.4 million and $210.3 million higher as of June 30, 2019 and 2018, respectively. Current cost of LIFO-valued inventories was $793.0 million at June 30, 2019 and $760.8 million at June 30, 2018. The reductions in LIFO-valued inventories decreased cost of sales by $0.0 million during fiscal year 2019 and $0.6 million during fiscal year 2018 and $0.0 million during fiscal year 2017.

June 30,
($ in millions)
2019
2018
Raw materials and supplies
$169.8
$157.5
Work in process
425.7
372.5
Finished and purchased products
192.2
159.2
Total inventory
$787.7
$689.2


Question: Analyse this data from a financial earnings document. What was the percentage change in Raw materials and supplies in 2019 from 2018?
Choices:
0.68
7.81
12.3
41
0.01
Correct choice index: 1
During the period 5.0 million (2017/18: 5.0 million) options were granted under the Sharesave Plan, with a weighted average exercise price at the date of exercise of 30 pence per ordinary share (2017/18: 33 pence).
The options outstanding at 30 March 2019 had a weighted average exercise price of 32 pence (2017/18: 33 pence), and a weighted average remaining contractual life of 1.6 years (2017/18: 1.6 years).
In 2018/19, the Group recognised an expense of £2.1m (2017/18: £2.8m), related to all equity-settled share-based payment transactions.
Premier Foods plc Sharesave Plan

2018/19
2017/18
Weighted average exercise price
Weighted average exercise price
Options
(p)
Options
(p)
Outstanding at the beginning of the period
17,835,628
33
20,231,334
35
Exercised during the period
(4,306,470)
32
(3,536,539)
34
Granted during the period
5,022,240
30
4,988,669
33
Forfeited/lapsed during the period
(2,447,511)
33
(3,847,836)
44
Outstanding at the end of the period
16,103,887
32
17,835,628
33
Exercisable at the end of the period
2,673,154
32
792,451
35


Question: Analyse this data from a financial earnings document. What was the change in the Outstanding at the beginning of the period for options from 2017/18 to 2018/19?
Choices:
22627040
2395706
-2395706000
38066962
-2395706
Correct choice index: 4
The 2019 operating expenses increased 3.9% compared to the prior year, mainly due to salary dynamic, increased spending in certain R&D programs and higher share-based compensation cost, partially offset by favorable currency effects, net of hedging.
The 2018 operating expenses increased 9.5% compared to the prior year, mainly due to unfavorable currency effects, net of hedging, salary dynamic, increased R&D activities and higher costs of the share-based compensation plans.
The R&D expenses were net of research tax credits in France and Italy, which amounted to $126 million in 2019, $138 million in 2018 and $124 million in 2017.

Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
Variation
Variation
2019
2018
2017
2019 vs 2018
2018 vs 2017
(In millions)
(In millions)
(In millions)
Selling, general and administrative expenses
$(1,093)
$(1,095)
$(981)
0.3%
(11.7)%
Research and development expenses
(1,498)
(1,398)
(1,296)
(7.1)
(7.9)
Total operating expenses
$(2,591)
$(2,493)
$(2,277)
(3.9)%
(9.5)%
As percentage of net revenues
(27.1)%
(25.8)%
(27.3)%
-130 bps
+150 bps


Question: Analyse this data from a financial earnings document. What is the average Research and development expenses?
Choices:
922.23
465.33
1397.33
-3.23
1015.33
Correct choice index: 2
performance graph the following graph compares the total return , assuming reinvestment of dividends , on an investment in the company , based on performance of the company's common stock , with the total return of the standard & poor's 500 composite stock index and the dow jones united states travel and leisure index for a five year period by measuring the changes in common stock prices from december 31 , 2011 to december 31 , 2016. .

12/11
12/12
12/13
12/14
12/15
12/16
Royal Caribbean Cruises Ltd.
100.00
139.36
198.03
350.40
437.09
362.38
S&P 500
100.00
116.00
153.58
174.60
177.01
198.18
Dow Jones US Travel & Leisure
100.00
113.33
164.87
191.85
203.17
218.56

the stock performance graph assumes for comparison that the value of the company's common stock and of each index was $ 100 on december 31 , 2011 and that all dividends were reinvested .
past performance is not necessarily an indicator of future results. .

Question: Analyse this data from a financial earnings document. what was the percentage increase in the stock performance of the royal caribbean cruises ltd . from 2012 to 2013
Choices:
58.67
0.421
0.422
420995.982
-80.69
Correct choice index: 1
Restricted Share Awards
Restricted share awards, which are generally in the form of restricted share units, are granted subject to certain restrictions. Conditions of vesting are determined at the time of grant. All restrictions on an award will lapse upon death or disability of the employee. If the employee satisfies retirement requirements, a portion of the award may vest, depending on the terms and conditions of the particular grant. Recipients of restricted share units have no voting rights, but do receive dividend equivalents. For grants that vest through passage of time, the fair value of the award at the time of the grant is amortized to expense over the period of vesting. The fair value of restricted share awards is determined based on the closing value of our shares on the grant date. Restricted share awards generally vest in increments over a period of four years as determined by the management development and compensation committee.
Restricted share award activity was as follows:
The weighted-average grant-date fair value of restricted share awards granted during fiscal 2019, 2018, and 2017 was $77.77, $93.45, and $67.72, respectively.
The total fair value of restricted share awards that vested during fiscal 2019, 2018, and 2017 was $48 million, $50 million, and $50 million, respectively.
As of fiscal year end 2019, there was $64 million of unrecognized compensation expense related to nonvested restricted share awards, which is expected to be recognized over a weighted-average period of 1.7 years.

Shares
Weighted-Average Grant-Date Fair Value
Nonvested at fiscal year end 2018
1,631,470
$  75.39
Granted
692,899
77.77
Vested
(689,040)
70.31
Forfeited
(232,910)
78.80
Nonvested at fiscal year end 2019
1,402,419
$  78.36


Question: Analyse this data from a financial earnings document. What was the change in the Weighted-Average Grant-Date Fair Value for nonvested shares in 2019 from 2018?
Choices:
1402343.61
-689037.03
2.97
14.36
2970000
Correct choice index: 2
As of December 31, 2019 and 2018, the fair value of the 2022 Notes, which was determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, quoted price of the 2022 Notes in an over-the-counter market (Level 2), and carrying value of debt instruments (carrying value excludes the equity component of the Company’s convertible notes classified in equity) were as follows (in thousands):
In connection with the issuance of the 2022 Notes, the Company entered into capped call transactions with certain counterparties affiliated with the initial purchasers and others. The capped call transactions are expected to reduce potential dilution of earnings per share upon conversion of the 2022 Notes.
Under the capped call transactions, the Company purchased capped call options that in the aggregate relate to the total number of shares of the Company’s common stock underlying the 2022 Notes, with an initial strike price of approximately $33.71 per share, which corresponds to the initial conversion price of the 2022 Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the 2022 Notes, and have a cap price of approximately $47.20.
The cost of the purchased capped calls of $12.9 million was recorded to shareholders’ equity and will not be re-measured.
Based on the closing price of the Company’s common stock of $78.08 on December 31, 2019, the if-converted value of the 2022 Notes was more than their respective principal amounts.

As of December 31,
2019
2018
Fair Value
Carrying Value
Fair Value
Carrying Value
2022 Notes
$215,801
$79,224
$ 189,802
$94,097


Question: Analyse this data from a financial earnings document. What is the average fair value for the period December 31, 2019 to December 31, 2018?
Choices:
202801.5
405603
94902
94924.6
5194.7
Correct choice index: 0
In addition to the results reported in accordance with accounting principles generally accepted in the United States (“US GAAP” or “GAAP”), we also use certain non-GAAP measures such as EBITDA and adjusted EBITDA to evaluate operating performance and to facilitate the comparison of our historical results and trends.
These financial measures are not a measure of financial performance under US GAAP and should not be considered in isolation or as a substitute for net income (loss) as a measure of performance and net cash provided by operating activities as a measure of liquidity.
EBITDA is defined as net earnings before interest expense, income taxes, and depreciation and amortization. Adjusted EBITDA is comprised of EBITDA, adjusted for certain items as permitted or required under our credit facility as described in the reconciliations below.
These measures are a common measure of operating performance in the telecommunications industry and are useful, with other data, as a means to evaluate our ability to fund our estimated uses of cash. The following tables are a reconciliation of net income (loss) to Adjusted EBITDA:
The following tables are a reconciliation of net income (loss) to Adjusted EBITDA:
(a) Other, net includes the equity earnings from our investments, dividend income, income attributable to noncontrolling interests in subsidiaries, acquisition and transaction related costs including severance, non-cash pension and postretirement benefits and certain other miscellaneous items.
(b) Includes all cash dividends and other cash distributions received from our investments.
(c) Represents the redemption premium (discount) and write-off of unamortized debt issuance costs in connection with the redemption or retirement of our debt obligations.
(d) Represents intangible asset impairment charges recognized during the period.
(e) Represents compensation expenses in connection with the issuance of stock awards, which because of their non-cash nature, these expenses are excluded from adjusted EBITDA.

Year Ended December 31,
(In millions, unaudited)
2019
2018
2017
2016
2015
Net income (loss)
$ (20.0)
$ (50.5)
$ 65.3
$ 15.2
$ (0.7)
Add (subtract):
Interest expense, net of interest income
136.7
134.5
129.8
76.8
79.6
Income tax expense (benefit)
(3.7)
(24.1)
(124.9)
23.0
2.8
Depreciation and amortization
381.2
432.6
291.8
174.0
179.9
EBITDA
494.2
492.5
362.0
289.0
261.6
Adjustments to EBITDA:
Other, net (a)
(8.8)
0.6
19.3
(25.5)
(22.3)
Investment distributions (b)
35.8
39.1
30.0
32.1
45.3
(Gain) loss on extinguishment of debt (c)
(4.5)
—
—
6.6
41.2
Loss on impairment (d)
—
—
—
0.6
—
Non-cash, stock-based compensation (e)
6.8
5.1
2.8
3.0
3.1
Adjusted EBITDA
$ 523.5
$ 537.3
$ 414.1
$ 305.8
$ 328.9


Question: Analyse this data from a financial earnings document. What is the increase/ (decrease) in Income tax expense (benefit) from 2018 to 2019?
Choices:
89.2
-27.8
0
20.4
-491.6
Correct choice index: 3
NOTE 11 – STOCK COMPENSATION
The Company sponsors a stock-based incentive compensation plan known as the 2013 Equity Compensation Plan (the “Plan”), which was established by the Board of Directors of the Company in June 2013. A total of 500,000 shares were initially reserved for issuance under the Plan. The Plan was amended several times since then to eventually increase the authorized shares to 2,500,000 as of December 31, 2019. A total of 1,624,221 shares of common stock underlying options were outstanding at December 31, 2019. The Company had 236,614 remaining shares available to grant under the Plan at December 31, 2019.
The Plan allows the Company to grant incentive stock options, non-qualified stock options, stock appreciation rights, or restricted stock. The incentive stock options are exercisable for up to ten years, at an option price per share not less than the fair market value on the date the option is granted. The incentive stock options are limited to persons who are regular full-time employees of the Company at the date of the grant of the option. Non-qualified options may be granted to any person, including, but not limited to, employees, independent agents, consultants and attorneys, who the Company’s Board or Compensation Committee believes have contributed, or will contribute, to the success of the Company. Non-qualified options may be issued at option prices of less than fair market value on the date of grant and may be exercisable for up to ten years from date of grant. The option vesting schedule for options granted is determined by the Compensation Committee of the Board of Directors at the time of the grant. The Plan provides for accelerated vesting of unvested options if there is a change in control, as defined in the Plan.
The compensation cost that has been charged against income related to options for the years ended December 31, 2019 and 2018, was $1,687,745 and $1,317,904, respectively. No income tax benefit was recognized in the income statement and no compensation was capitalized in any of the years presented.
The Company had the following option activity during the years ended December 31, 2019 and 2018:
Of the options outstanding at December 31, 2019, 1,143,637 were exercisable with a weighted average contractual life of 1.9 years.

Number of Options
Weighted average exercise price
Weighted average remaining contractual life (years)
Aggregate intrinsic value $
Outstanding, January 1, 2018
1,368,772
$3.12
Granted – 2018
401,099
$9.27
Exercised – 2018
(165,169)
$3.16
Expired – 2018
(50,002)
$5.48
Outstanding, December 31, 2018
1,554,700
$4.63
3.0
Granted – 2019
410,134
$12.28
Exercised – 2019
(251,063)
$3.73
Expired – 2019
(89,550)
$12.55
Outstanding, December 31, 2019
1,624,221
$6.27
2.6
$7,925,643
Exercisable, December 31, 2019
1,143,637
$4.39
1.9
$7,197,053


Question: Analyse this data from a financial earnings document. What is the total price of exercised or expired options during the fiscal year 2019?
Choices:
187387.51
25856984.5
2060317.49
2006422.72
1123866.41
Correct choice index: 2
Discontinued Operations
In December 2015, we completed the wind down of engineering, manufacturing and sales of our solar inverter product line (the "inverter business"). Accordingly, the results of our inverter business have been reflected as “Income (loss) from discontinued operations, net of income taxes” on our Consolidated Statements of Operations for all periods presented herein.
The effect of our sales of extended inverter warranties to our customers continues to be reflected in deferred revenue in our Consolidated Balance Sheets. Deferred revenue for extended inverter warranties and the associated costs of warranty service will be reflected in Sales and Cost of goods sold, respectively, from continuing operations in future periods in our Consolidated Statement of Operations, as the deferred revenue, is earned and the associated services are rendered. Extended warranties related to the inverter product line are no longer offered.
ADVANCED ENERGY INDUSTRIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (continued) (in thousands, except per share amounts)
Assets and Liabilities of discontinued operations within the Consolidated Balance Sheets are comprised of the following:

December 31,
2019
2018
Cash and cash equivalents
$  —
$ 5,251
Accounts and other receivables, net
—
406
Inventories
30
198
Current assets of discontinued operations
30
5,855
Other assets
—
67
Deferred income tax assets
269
5,917
Non-current assets of discontinued operations
269
5,984
Accounts payable and other accrued expenses
—
350
Accrued warranty
914
4,936
Current liabilities of discontinued operations
914
5,286
Accrued warranty
698
10,429
Other liabilities
189
286
Non-current liabilities of discontinued operations
$887
$10,715


Question: Analyse this data from a financial earnings document. What was the change in Accrued warranty of Accounts payable and other accrued expenses between 2018 and 2019?
Choices:
4022
-4238
-4022
-1
628
Correct choice index: 2
Year Ended December 31, 2019 Compared to Year Ended December 31, 2018
Revenues
Our Products and Licensing segment included revenues from sales of test and measurement systems, primarily representing sales of our Optical Backscatter Reflectometer, ODiSI, and Optical Vector Analyzer platforms, optical components and sub-assemblies and sales of our Hyperion and Terahertz sensing platforms. Our Products and Licensing segment revenues increased $22.5 million to $44.5 million for the year ended December 31, 2019 compared to $21.9 million for the year ended December 31, 2018.
The increase resulted primarily from $10.8 million of revenues realized from the legacy business of MOI and $10.5 million of revenues realized from the legacy business of GP during the year ended December 31, 2019. Continued growth in sales of our fiber-optic sensing products, including our ODiSI products directed toward the expanding use of composite materials and the need for improved means of testing their structural integrity, and our communications test instruments also contributed to this increase.
Our Technology Development segment revenues increased $5.1 million to $26.0 million for the year ended December 31, 2019 compared to $21.0 million for the year ended December 31, 2018. Revenues within this segment increased due to additional contract awards, including higher value Phase 2 SBIR contracts. The increase continues a growth trend experienced over the past two years largely driven by successes in Phase 2 SBIR awards. The increase was realized primarily in our intelligent systems, advanced materials, optical systems and terahertz research groups. As Phase 2 SBIR contracts generally have a performance period of a year or more, we currently expect Technology Development segment revenues to remain at a similar level for the near term.

Years ended December 31,
2019
2018
$ Difference 
% Difference
Products and licensing revenues
$44,491,041
$21,949,689
$22,541,352
102.7%
Technology development revenues
26,024,674
20,967,556
5,057,118
24.1%
Total revenues
$70,515,715
$42,917,245
$27,598,470
64.3%


Question: Analyse this data from a financial earnings document. What is the average Technology development revenues for December 31, 2018 and 2019?
Choices:
-23496115
13012337
23496113
23496115
1
Correct choice index: 3